ENPP2 and ovarian cancer: ENPP2 has indeed been identified as a candidate gene causing drug resistance in the long-term treatment of ovarian cancer, and stable ectopic expression of ATX in OVCAR-3 ovarian cancer cells delays apoptosis induced by carboplatin [39].